PAX5alt, TCF3::PBX1 and ZNF384-R B-ALL

1. PAX5alt, TCF3::PBX1 and ZNF384-R B-ALL is associated with MRD-negativity in humans after induction and intensification chemotherapy.

   “Attainment of MRD-negativity patients after induction and intensification chemotherapy was more common in PAX5alt, TCF3::PBX1 and ZNF384-R B-ALL”

   Human trialafter induction and intensification chemotherapy

   Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study

   Blood·Oct 5, 2026

More on MRD-negativity